Demo Sign up Log In

AstraZeneca PLC Ordinary Shares (AZN)

Income Tax Expense

$2.13B

TTM · Period ending: Jun 30, 2026 · USD

AZN Income Tax Expense

Latest reported$2.13Bperiod endingJun 30, 2026

Latest reported$2.13Bperiod endingJun 30, 2026

AZN TTM Income Tax ($0.00 → $2.13B)

TTM income tax expense

High-resolution chart · PNG

AZN income tax expense history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

AstraZeneca PLC Ordinary Shares Income Tax Expense — Trailing twelve months (TTM) (USD)
Period ending	Income Tax Expense (USD)
Jun 30, 2001	1,307,362,545
Mar 31, 2001	1,337,784,952
Dec 31, 2000	1,299,438,400
Sep 30, 2000	756,047,593
Jun 30, 2000	765,674,317
Mar 31, 2000	772,251,910
Dec 31, 1999	502,599,780
Sep 30, 1999	594,000,000
Jun 30, 1999	312,000,000
Mar 31, 1999	318,000,000
Dec 31, 1998	318,000,000
Sep 30, 1998	318,000,000
Jun 30, 1998	318,000,000
Mar 31, 1998	0
Dec 31, 1997	0
Sep 30, 1997	0
Jun 30, 1997	0
Mar 31, 1997	0
Dec 31, 1996	0
Sep 30, 1996	0
Jun 30, 1996	0
Mar 31, 1996	128,400,000
Dec 31, 1995	128,400,000
Sep 30, 1995	128,400,000
Jun 30, 1995	128,400,000
Mar 31, 1995	0
Dec 31, 1994	0
Sep 30, 1994	0
Jun 30, 1994	0
Mar 31, 1994	0
Dec 31, 1993	0

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.